Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens-Reference-Cited by-同舟云学术

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

Published:2018-11 Issue:5 Volume:200 Page:956-966
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Crawford E. David¹,Schellhammer Paul F.²,McLeod David G.³,Moul Judd W.⁴,Higano Celestia S.⁵,Shore Neal⁶,Denis Louis⁷,Iversen Peter⁸,Eisenberger Mario A.⁹,Labrie Fernand¹⁰

Affiliation:

1. University of Colorado-Denver, Aurora, Colorado

2. Eastern Virginia Medical School, Norfolk, Virginia

3. Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Bethesda

4. Duke Cancer Institute, Duke University, Durham, North Carolina

5. Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington

6. Carolina Urologic Research Center, Myrtle Beach, South Carolina

7. Europa Uomo, Oncology Centre Antwerp, Antwerp, Belgium

8. Copenhagen Prostate Cancer Center, University of Copenhagen, Copenhagen, Denmark

9. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

10. Endoceutics, Quebec City, Quebec, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference50 articles.

1. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. The development of androgen-independent prostate cancer;Feldman;Nat Rev Cancer,2001

3. Complete androgen blockade for the treatment of prostate cancer;Labrie,1985

4. New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen;Labrie;Clin Invest Med,1982

5. The changing natural history of metastatic prostate cancer;Alva;Cancer J,2013

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity;Inorganic Chemistry;2024-09-11

2. Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy;American Journal of Clinical Oncology;2024-08-01

3. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines;International Journal of Molecular Sciences;2024-07-19

4. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies;ESMO Open;2024-07

5. Amplifying Flutamide Sensing through the Synergetic Combination of Actinidia-Derived Carbon Particles and WS₂ Platelets;ACS Omega;2024-06-26